Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Daiichi Sankyo Datroway approved in Japan for breast cancer

Written By Ruchika Sharma29 Dec 2024 12:00 PM IST

Tokyo: Daiichi Sankyo's DATROWAY (datopotamab deruxtecan) has been approved in Japan for the treatment of adult patients with hormone receptor...

BioNTech enters settlement with US National Institutes of Health, University of Pennsylvania

Written By Ruchika Sharma29 Dec 2024 10:00 AM IST

Bengaluru: German biotechnology company BioNTech has reached two separate settlement agreements with the U.S. National Institutes of Health (NIH)...

Injectable version of Bristol Myers Squibb cancer drug Opdivo gets USFDA okay

Written By Ruchika Sharma28 Dec 2024 12:30 PM IST

Opdivo Qvantig offers a faster delivery for patients to receive this immunotherapy treatment option in three to five minutes compared to 30 minute IV...

Inspection Finds Bilaspur Ayurvedic Hospital Functioning Smoothly

Shilpa Medicare receives Eurasia GMP approval for 2 Telangana units

Written By Ruchika Sharma28 Dec 2024 11:30 AM IST

Karnataka: In a BSE filing, Shilpa Medicare informed that its Unit IV and Unit VII in Telangana have received Good Manufacturing Practice...

Pharma firm employee arrested for running clandestine recreational drug manufacturing lab

Written By Ruchika Sharma27 Dec 2024 1:30 PM IST

New Delhi: An employee of a pharma company has been arrested for running a "clandestine" recreational drug manufacturing lab in...

Teen Girl Dies After Injection at Khargone Clinic, Family Alleges Negligence

Takeda gets Japenese nod for Hyqvia 10% SC injection set for Agammaglobulinemia

Written By Ruchika Sharma27 Dec 2024 12:32 PM IST

Osaka: Takeda has announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of HYQVIA [Immune Globulin...

AstraZeneca Commits USD 405 Million to UK Life Sciences Amid Policy Shift

AstraZeneca Tagrisso approved in EU for patients with unresectable EGFR-mutated lung cancer

Written By Ruchika Sharma27 Dec 2024 11:30 AM IST

Cambridge: AstraZeneca's Tagrisso (osimertinib) has been approved in the European Union (EU) for the treatment of adult patients with...

JnJ wins USFDA approval for subcutaneous Rybrevant Faspro for EGFR-Mutated NSCLC

JnJ enters licensing agreement for global development, manufacturing, commercialization of STAT6 program from Kaken Pharma

Written By Ruchika Sharma27 Dec 2024 10:00 AM IST

New Brunswick: Johnson & Johnson has announced that it has entered into an exclusive licensing agreement for the global...

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck to discontinue bacterial infection drug Zinplava

Written By Ruchika Sharma26 Dec 2024 5:44 PM IST

Merck will discontinue its antibody-drug Zinplava for a bacterial infection that can lead to fatal diarrhea, according to the U.S. Food and...

Gland Pharma profit rises 12 percent to Rs 184 crore in Q2

Gland Pharma arm Fontenay facility gets 10 observations from France drug regulator

Written By Ruchika Sharma26 Dec 2024 11:30 AM IST

Telangana: Through a recent BSE filing, Gland Pharma has informed that its material subsidiary, Cenexi's Fontenay manufacturing...

USFDA updates Camzyos label to reduce echocardiography monitoring requirements, contraindications: Bristol Myers Squibb

Bristol Myers Squibb gets European Commission nod for Opdivo plus Yervoy to treat colorectal cancer

Written By Ruchika Sharma25 Dec 2024 4:52 PM IST

Princeton: Bristol Myers Squibb has announced that the European Commission (EC) has approved Opdivo (nivolumab) plus...

Indian Pharma Market Kicks Off 2026 With 10% Growth in January: PharmaTrac

GPT Healthcare shares listed with over 16 percent premium

Written By Ruchika Sharma25 Dec 2024 1:11 PM IST

New Delhi: GPT Healthcare Ltd shares listed with a premium of over 16 percent on Thursday against the issue price of Rs 186. GPT Healthcare Ltd...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok